Literature DB >> 1935793

Characterization of the microheterogeneity of recombinant primate prolactin: implications for posttranslational modifications of the hormone in vivo.

E S Cole1, E H Nichols, K Lauziere, T Edmunds, J M McPherson.   

Abstract

Recombinant baboon and monkey prolactins were expressed in murine C127 cells. The hormones were purified from the conditioned media of these cells using a combination of cation, anion, and gel filtration chromatographies. This purification scheme provided approximately a 20-fold purification of the proteins with a 40% cumulative yield. Sodium dodecyl sulfate gel electrophoresis of the purified hormones in conjunction with Coomassie blue staining and immunoblotting procedures revealed three major prolactin-related bands with molecular weights corresponding to Mr 16,000, 23,000, and 27,000. Based on these analyses the samples were judged to be greater than 90% pure. Amino terminal sequence analysis of the purified baboon and monkey hormones provided three distinct prolactin-related sequences for each preparation. The predominant sequence corresponded to the predicted amino terminal sequences of the hormones which began with leucine at position 1. Two minor sequences, individually representing approximately 10-20% of the total population, were also identified; one starting at position 11 and the other at position 133. Carbohydrate compositional analysis of the proteins suggested that greater than 50% of the population were glycosylated with a fucosylated complex oligosaccharide. Analysis of the specific bioactivity of the recombinant hormones in the Nb2 cell proliferation assay showed them to be comparable to the NIH and WHO human pituitary-derived standards.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1935793     DOI: 10.1210/endo-129-5-2639

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Heterogeneity in buffalo pituitary prolactin.

Authors:  S Khurana; K Muralidhar
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

2.  Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.

Authors:  L Matera; G Bellone; J J Lebren; P A Kelly; E L Hooghe Peters; P F Di Celle; R Foa; M Contarini; G Avanzi; V Asnaghi
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

3.  Glycosylated equine prolactin and its carbohydrate moiety.

Authors:  V Y Butnev; R R Gotschall; V L Baker; W T Moore; P W Gout; G R Bousfield
Journal:  J Protein Chem       Date:  1996-07

4.  The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin.

Authors:  C Clapp; L Torner; G Gutiérrez-Ospina; E Alcántara; F J López-Gómez; M Nagano; P A Kelly; S Mejía; M A Morales; G Martínez de la Escalera
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

5.  The effect of protein synthesis inhibitors on the glycosylation site occupancy of recombinant human prolactin.

Authors:  M Shelikoff; A J Sinskey; G Stephanopoulos
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.